Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin vs topical capsaicin for postmastectomy pain syndrome (pilot)
2024-513609-29-01Phase 4Completed
- Sponsor
- Foundation for the Incentive of Research
- Start
- Sep 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in Post-mastectomy pain syndrome (PMPS) comparing Xeomin arm with Qutenza arm (2 arms). Primary endpoints: Pain intensity (VAS) and Predominant pain perception characterization. Started Sep 2024; status: completed.
02
Drugs
botulinum toxin type Acapsaicin
03
Conditions
Post-mastectomy pain syndrome (PMPS)
Beyond the preview
Go deeper on 2024-513609-29-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513609-29-01.